Trends in Prevalence of 11 Site-specific Musculoskeletal Pain Among U.S. Adults, 1999-2018

NCT ID: NCT06494670

Last Updated: 2024-07-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

565219 participants

Study Classification

OBSERVATIONAL

Study Start Date

1999-01-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to explore the prevalence trends of 11 site-specific musculoskeletal pain from 1999 to 2018. The main question it aims to answer is:

Does the prevalence of musculoskeletal pain among U.S. adults changed from 1999 to 2018? What are the trends?

Participants will answer survey questions about their musculoskeletal pain on the past three months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Musculoskeletal (MSK) pain refers to pain, either acute or chronic, affecting muscles, bones, joints, tendons, and even nerves. Common types include low back pain, neck pain, and the pain associated with osteoarthritis. These pains are the leading cause of work disability, sick leave, presenteeism, and reduced productivity. MSK pain is the leading cause of disability in the United States in 2021, ranking first in years lived with disability and fourth in disability-adjusted life years. Moreover, MSK pain is often chronic and progressive, placing a considerable strain on healthcare systems and financial resources. Estimates of US healthcare spending in 2016 revealed that low back and neck pain had the highest costs, at $134.5 billion, followed by other MSK pain, which accounted for $129.8 billion.

As the U.S. population ages, the prevalence of MSK issues may rise, leading to increased demands on the healthcare system. Although the Bone and Joint Decade 2000-2010 raised awareness about the burden of MSK conditions, significant gaps in health system improvements persist. National health policies and strategies addressing MSK health as part of noncommunicable disease care remain inadequate relative to the burden of these condition such as cardiovascular disease. Achieving the 2030 Agenda for Sustainable Development and promoting health throughout life requires a renewed and sustained focus on improving MSK health at both national and global levels. Tracking the prevalence trends of MSK pain may offer valuable insights into critical public health issues, including shifts in disease burden, healthcare access, adoption of effective therapies, and reduction in the use of inappropriate or ineffective treatments. However, previous studies have mostly focused on low back pain, and neck pain. To date, very few studies have examined trends of site-specific MSK pain prevalence using national representative sample. Prevalence and trends in other sites are also important, but no relevant studies were found. The absence of such data poses challenges in accurately estimating the burden of MSK pain.

In addition, in disease trend analysis, temporal trends generally encompass multiple dimensions. For individuals with MSK pain, prevalence risk can be divided into age, period, and birth cohort effects. Age effects reflect the influence of an individual's chronological age on MSK pain prevalence. Period effects pertain to the influence of external factors on the whole population at a particular time. These factors may include changes in medical technology, public health policies, or social and economic conditions. Cohort effects reflect the impact of common experiences and exposures unique to a particular generation or birth cohort, regardless of period or age. Understanding the contribution of age-period-cohort effects and identifying potential moderating factors for each enhances comprehension of macro-level exposures, aiding in data-driven planning.

Furthermore, Healthy People 2010 and 2020, the U.S. national public health blueprint, targeted the elimination of health disparities, including those related to MSK pain, and the attainment of health equity. To assess progress toward this objective, it is crucial to evaluate disparities in MSK pain prevalence.

In this study, utilizing a large, nationally representative sample of the US population, our objective was to explore the prevalence trends of 11 site-specific MSK pain from 1999 to 2018. We also identified cohort patterns in MSK pain prevalence, isolating age, period and cohort effects. Furthermore, we also investigated these trends across various demographic factors such as race/ethnicity, gender, age, and socioeconomic status to determine whether health disparities persist.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Musculoskeletal Pain Neck Pain Low Back Pain Joint Pain Shoulder Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

This study was a cross-sectional study with no intervention for participants

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Residents of households and noninstitutional group quarters (e.g., homeless shelters, rooming houses, and group homes);
* Persons residing temporarily in student dormitories or temporary housing are sampled within the households that they reside in permanently.

Exclusion Criteria

* Persons with no fixed household address (e.g., homeless and/or transient persons not residing in shelters);
* Active duty military personnel and civilians living on military bases, persons in long-term care institutions (e.g., nursing homes for the elderly, hospitals for the chronically ill or physically or intellectually disabled, and wards for abused or neglected children);
* Persons in correctional facilities (e.g., prisons or jails, juvenile detention centers, and halfway houses), and U.S. nationals living in foreign countries.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fan luying

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Fan luying

Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

82173608

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

81974019

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

2022JJ40207

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

CSU202407

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Chronotype and Myofascial Pain Syndrome,
NCT06707675 NOT_YET_RECRUITING